Viatris (VTRS) stock and Opus Genetics (IRD) stock gain as the FDA reviews a label expansion for their jointly developed eyecare therapy, Ryzumvi. Read more here.

Min Read In late February, people in the Northern Hemisphere can look up for a special sight : Six planets will all be ...